To provide the information your oncologist is not telling you or doesn't have the time to!
Explore a comprehensive range of insights and information within our ‘Varied Cancer Perspectives’ category. From melanoma to breast cancer, colorectal cancer to sarcoma, and beyond, this diverse collection delves into the multifaceted world of oncology. Gain a nuanced understanding of different cancer types, treatments, and the latest advancements in research. Whether you’re seeking knowledge on pediatric oncology, uveal melanoma, or desmoid tumors, our curated content provides a holistic view, offering valuable perspectives to empower and inform those navigating the complexities of cancer care. Join us on a journey through varied perspectives, ensuring a well-rounded understanding of the ever-evolving landscape of cancer.
by Sajeve Thomas, MD, Oncologist Biliary tract cancer (BTC), a rare and aggressive form of cancer affecting the bile ducts, gallbladder, and liver, has historically been challenging to treat. However, there is hope on the horizon with the recent FDA approval of pembrolizumab (Keytruda, Merck) in combination with chemotherapy. This groundbreaking development offers new possibilities …
On November 7, 2023, the Food and Drug Administration (FDA) made significant updates to the existing indication of pembrolizumab (Keytruda, Merck) for the first-line treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma. These changes come as part of the FDA’s commitment to advancing cancer treatment options, bringing …
Neuroendocrine tumors (NETs) are a rare type of cancer that originates in the neuroendocrine cells, which are found throughout the body. While these tumors can occur in various organs such as the pancreas, lungs, intestines, and appendix, they can also develop in other less common sites. In this article, we will dive into the basics …
I am very excited to announce the opening of a new Cellular Therapy by Tscan Therapeutics using TCR protocol at the Orlando Health Cancer Institute (OHCI) targeting Melanoma, Head/Neck Cancer, NSCLC, Ovarian, and HPV positive Anal-Cervical SCC. Information for this new open clinical trial was provided from a public source. Please reach out to Karin …
Embarking on the tumultuous journey that is stage IV melanoma, both patients and healthcare providers often find themselves in an intricate dance of vulnerability, resilience, and human connection. This is the poignant tale of a young man’s persistent battle against melanoma, his remarkable perseverance through a myriad of treatments, and the eventual moment of triumph …
This post is based on the interesting results published by Routy et al. Nature July 2023. I am hoping that we will soon open a protocol using FMT in cancer patients and I will announce once we’re site activated at the Orlando Health Cancer Institute. The revolutionary world of cancer treatment is once again on …
Breast cancer is a significant health concern affecting women worldwide. With October being Breast Cancer Awareness Month, it is crucial for women to understand the importance of regular breast cancer screenings. Regular screenings, including mammograms and self-exams, play a vital role in detecting breast cancer early, improving treatment outcomes, and saving lives. In this article, …
A breast cancer diagnosis is a life-altering event that extends its impact far beyond the physical realm. It sends ripples through the emotional and psychological landscape, affecting not only the patient but also their families. In recognition of Breast Cancer Awareness Month, let’s delve into the emotional journey that often accompanies a breast cancer diagnosis …
Breast cancer, a formidable adversary, affects millions of lives worldwide each year. In our quest to combat this disease, knowledge is the most potent weapon we have. Breast Cancer Awareness Month is the ideal time to explore the intricacies of breast cancer risk factors, from the genetic underpinnings to lifestyle choices that can influence your …
Uveal melanoma, a rare and aggressive form of eye cancer, has just witnessed a groundbreaking development in its treatment landscape. The Food and Drug Administration (FDA) recently granted approval to the HEPZATO KIT, an innovative liver-directed therapy that offers new hope to adult patients with uveal melanoma and unresectable hepatic metastases.